Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Operating-Expenses" stands at 791.26 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.
Daiichi Sankyo Co. Ltd.'s first quarter result of 179.59 Billion JPY for the item "Other Operating Expenses" represents a decrease of -23.91 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 179.59 Billion JPY for the item "Other Operating Expenses" represents an increase of 21.81 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 791.26 Billion JPY for the item "Other Operating Expenses" represents an increase of 4.24 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 643.85 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 643.85 Billion Japanese Yens.
The 3 year change is 818.48 Billion Japanese Yens.
The 5 year change is 907.22 Billion Japanese Yens.
The 10 year change is 937.99 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Operating Expenses | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Operating Expenses | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Operating Expenses | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Operating Expenses | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Operating Expenses | 280,205,508,085.11 |